Muñoz-Blanco A, Gómez-Huelgas R, Gómez-Cerezo J F
Servicio de Medicina Interna, Hospital Infanta Sofía, San Sebastián de los Reyes, Madrid, Spain.
Servicio de Medicina Interna, Hospital Regional Universitario Carlos Haya, Málaga, Spain.
Rev Clin Esp (Barc). 2022 Dec;222(10):602-611. doi: 10.1016/j.rceng.2022.03.006. Epub 2022 Jul 6.
Statin-associated muscle symptoms is an entity that encompasses a constellation of various clinical manifestations of variyng severity. Since the introduction of the first statins, numerous studies have been published regarding its incidence, pathophysiology, diagnosis and treatment; however, to this day these aspects are still controversial. With the progressive increase in the use of statins in the general population, notifications of adverse reactions related to its use have multiplied, particularly those related to muscular toxicity. Nevertheless, the differences between the published studies, both in methodology and in the results obtained, make this relationship a complex issue of great interest for clinicians and patients. The integration of the evidence that we currently have can help us understand better this entity and facilitate its management in clinical practice.
他汀类药物相关肌肉症状是一个涵盖各种严重程度不同的临床表现的集合体。自第一种他汀类药物问世以来,已经发表了大量关于其发病率、病理生理学、诊断和治疗的研究;然而,时至今日,这些方面仍然存在争议。随着他汀类药物在普通人群中的使用逐渐增加,与其使用相关的不良反应报告也成倍增加,尤其是与肌肉毒性相关的报告。尽管如此,已发表研究在方法和所得结果上的差异,使得这种关系成为临床医生和患者都极为关注的复杂问题。整合我们目前所拥有的证据有助于我们更好地理解这一实体,并在临床实践中促进对其的管理。